Related Experiment Video
Updated: Jul 18, 2025

07:25
Author Spotlight: Investigating Liver Cancer Pathogenesis Using Patient-Derived Organoids
Published on: August 18, 2023
1.7K
CRISPR-edited hepatic organoids as drug screening platform for non-alcoholic fatty liver disease
1Department of Liver Surgery, Peking Union Medical College (PUMC) Hospital, Peking Union Medical College (PUMC) & Chinese Academy of Medical Sciences (CAMS), Beijing, China.
Hepatobiliary Surgery and Nutrition
|August 21, 2023
Abstract
No abstract available in PubMed .

